Owen Randel G

SEC source: 0000840489-26-000010 · wk-form4_1769800838.xml · nonDerivative · entry 1

Owen Randel G · CIK 0001346846 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,484

F1 · shares: Reflects a grant of restricted stock units ("RSUs") that shall vest on December 31, 2026 pursuant to the terms of the RSU award agreement or on a pro rata portion upon the termination of service other than for cause, with such pro rata portion determined based on the number of whole months that elapsed from the Grant Date to the termination of service; the vesting and payment of these RSUs will be accelerated if there is a change-in-control of the Company and the Units are not assumed by the surviving entity or otherwise equitably converted or substituted in connection with the Change in Control.

SEC source: 0000840489-25-000135 · wk-form4_1763679883.xml · nonDerivative · entry 1

Owen Randel G · CIK 0001346846 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,651

F1 · shares: Sale is pursuant to a 10b5-1 Preset Diversification Program dated August 20, 2025 under which Mr. Owen sold, in the aggregate, a total of 1,500 shares of FirstCash Holdings, Inc. common stock which was completed as of November 20, 2025.

SEC source: 0000840489-25-000017 · wk-form4_1738362610.xml · nonDerivative · entry 1

Owen Randel G · CIK 0001346846 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,151

F1 · shares: Reflects a grant of restricted stock units ("RSUs") that shall vest on December 31, 2025 pursuant to the terms of the RSU award agreement or on a pro rata portion upon the termination of service other than for cause, with such pro rata portion determined based on the number of whole months that elapsed from the Grant Date to the termination of service; the vesting and payment of these RSUs will be accelerated if there is a change-in-control of the Company and the Units are not assumed by the surviving entity or otherwise equitably converted or substituted in connection with the Change in Control.

SEC source: 0000840489-24-000133 · wk-form4_1730939464.xml · nonDerivative · entry 1

Owen Randel G · CIK 0001346846 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,888

F1 · shares: Sale is pursuant to a 10b5-1 Preset Diversification Program dated August 1, 2024 under which Mr. Owen sold a total of 2,000 shares of FirstCash Holdings, Inc. common stock which was completed as of November 6, 2024.

SEC source: 0000840489-24-000026 · wk-form4_1706901742.xml · nonDerivative · entry 1

Owen Randel G · CIK 0001346846 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,888

F1 · shares: Reflects a grant of restricted stock units ("RSUs") that shall vest on December 31, 2024 pursuant to the terms of the RSU award agreement or on a pro rata portion upon the termination of service other than for cause, with such pro rata portion determined based on the number of whole months that elapsed from the Grant Date to the termination of service; the vesting and payment of these RSUs will be accelerated if there is a change-in-control of the Company and the Units are not assumed by the surviving entity or otherwise equitably converted or substituted in connection with the Change in Control.

SEC source: 0000840489-23-000121 · wk-form4_1699574002.xml · nonDerivative · entry 1

Owen Randel G · CIK 0001346846 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,675

F1 · shares: Sale is pursuant to a 10b5-1 Preset Diversification Program dated August 10, 2023 under which Mr. Owen sold a total of 2,000 shares of FirstCash Holdings, Inc. common stock which was completed as of November 9, 2023.

SEC source: 0001209191-23-054367 · doc4.xml · nonDerivative · entry 1

Owen Randel G · CIK 0001346846 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,860

F1 · kind: The restricted stock units vest in one installment on May 5, 2024, subject to the reporting person's continued service on the board of directors.

SEC source: 0000840489-23-000023 · wf-form4_167545569424622.xml · nonDerivative · entry 1

Owen Randel G · CIK 0001346846 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,675

F1 · shares: Reflects a grant of restricted stock units ("RSUs") that shall vest on December 31, 2023 pursuant to the terms of the RSU award agreement or on a pro rata portion upon the termination of service other than for cause, with such pro rata portion determined based on the number of whole months that elapsed from the Grant Date to the termination of service; the vesting and payment of these RSUs will be accelerated if there is a change-in-control of the Company and the Units are not assumed by the surviving entity or otherwise equitably converted or substituted in connection with the Change in Control. The number of RSUs was determined by dividing $135,000 by $89.85, the 45 day trailing average of the closing price of the Company's common stock on Nasdaq on the day of the grant.

SEC source: 0000840489-22-000022 · wf-form4_164435892966086.xml · nonDerivative · entry 1

Owen Randel G · CIK 0001346846 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,172

F1 · shares: Reflects a grant of restricted stock units ("RSUs") that shall vest on December 31, 2022 pursuant to the terms of the RSU award agreement or on a pro rata portion upon the termination of service other than for cause, with such pro rata portion determined based on the number of whole months that elapsed from the Grant Date to the termination of service; the vesting and payment of these RSUs will be accelerated if there is a change-in-control of the Company and the Units are not assumed by the surviving entity or otherwise equitably converted or substituted in connection with the Change in Control. The number of RSUs was determined by dividing $110,000 by $69.11, the 45 day trailing average of the closing price of the Company's common stock on Nasdaq on the day of the grant.

SEC source: 0000840489-21-000013 · wf-form4_161186905985773.xml · nonDerivative · entry 1

Owen Randel G · CIK 0001346846 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,580

F1 · shares: Reflects a grant of restricted stock units ("RSUs") that shall vest on December 31, 2021 pursuant to the terms of the RSU award agreement or on a pro rata portion upon the termination of service other than for cause, with such pro rata portion determined based on the number of whole months that elapsed from the Grant Date to the termination of service; the vesting and payment of these RSUs will be accelerated if there is a change-in-control of the Company and the Units are not assumed by the surviving entity or otherwise equitably converted or substituted in connection with the Change in Control. The number of RSUs was determined by dividing $110,000 by $66.26, the 45 day trailing average of the closing price of the Company's common stock on Nasdaq on the day of the grant.

SEC source: 0000840489-20-000010 · wf-form4_158042880336981.xml · nonDerivative · entry 1

Owen Randel G · CIK 0001346846 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,920

F1 · shares: Reflects a grant of restricted stock units ("RSUs") that shall vest on December 31, 2020 pursuant to the terms of the RSU award agreement or on a pro rata portion upon the termination of service other than for cause, with such pro rata portion determined based on the number of whole months that elapsed from the Grant Date to the termination of service; the vesting and payment of these RSUs will be accelerated if there is a change-in-control of the Company and the Units are not assumed by the surviving entity or otherwise equitably converted or substituted in connection with the Change in Control. The number of RSUs was determined by dividing $110,000 by $81.93, the 45 day trailing average of the closing price of the Company's common stock on Nasdaq on the day of the grant.

SEC source: 0000840489-19-000021 · wf-form4_155079223618088.xml · nonDerivative · entry 1

Owen Randel G · CIK 0001346846 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,577

F1 · shares: Reflects a grant of restricted stock units ("RSUs") that shall vest on December 31, 2019 pursuant to the terms of the RSU award agreement or on a pro rata portion upon the termination of service other than for cause, with such pro rata portion determined based on the number of whole months that elapsed from the Grant Date to the termination of service; the vesting and payment of these RSUs will be accelerated if there is a change-in-control of the Company and the Units are not assumed by the surviving entity or otherwise equitably converted or substituted in connection with the Change in Control. The number of RSUs was determined by dividing $100,000 by $78.59, the 45 day trailing average of the closing price of the Company's common stock on Nasdaq on the day of the grant.

SEC source: 0001678531-18-000049 · wf-form4_152123120778140.xml · nonDerivative · entry 2

Owen Randel G · CIK 0001346846 · President Ambulatory Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,250

F2 · shares: On March 14, 2018, 5,656 unvested restricted stock units (RSUs) granted to the reporting person on March 2, 2017, which were previously reported in Table I as beneficially owned, were accelerated. Represents shares surrendered to the issuer upon payment of tax liability by withholding securities upon the acceleration date in accordance with Rule 16b-3.

SEC source: 0001678531-18-000049 · wf-form4_152123120778140.xml · nonDerivative · entry 1

Owen Randel G · CIK 0001346846 · President Ambulatory Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,890

F1 · shares: On March 14, 2018, in connection with reporting person's departure from the Company, the reporting person's unvested performance stock unit awards (PSUs) were accelerated at target amounts. Represents 6,040 shares received upon acceleration of PSUs granted on February 24, 2016, and 8,378 shares received upon acceleration of PSUs granted on March 2, 2017.

SEC source: 0001678531-18-000043 · wf-form4_152028958414108.xml · nonDerivative · entry 1

Owen Randel G · CIK 0001346846 · President Ambulatory Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,472

F1 · shares: Payment of tax liability by withholding securities which vested on the transaction date in accordance with rule 16b-3.

SEC source: 0000840489-18-000011 · wf-form4_151750856543954.xml · nonDerivative · entry 1

Owen Randel G · CIK 0001346846 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,305

F1 · shares: Reflects a grant of restricted stock units ("RSUs") that shall vest one year from the date of grant pursuant to the terms of the RSU award agreement or on a pro rata portion upon the termination of service other than for cause, with such pro rata portion determined based on the number of whole months that elapsed from the Grant Date to the termination of service; the vesting and payment of these RSUs will be accelerated if there is a change-in-control of the Company and the Units are not assumed by the surviving entity or otherwise equitably converted or substituted in connection with the Change in Control. The number of RSUs was determined by dividing $90,000 by $72.75, the average of the high and low price of the Company's common stock on the New York Stock Exchange on the day of the grant.

SEC source: 0001678531-17-000074 · wf-form4_148883933137784.xml · nonDerivative · entry 1

Owen Randel G · CIK 0001346846 · President Ambulatory Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,290

F1 · shares: Represents restricted stock units that are scheduled to vest and settle into an equal number of shares of the Issuer's Common Stock, in three installments on each of the first three anniversaries of March 2, 2017, subject to the Reporting Person's continued employment.

F2 · balance_after: The number of shares of common stock reported as beneficially owned by the reporting person has been reduced by one share in order to correct a clerical error in the previous Form 4 filing.

SEC source: 0000840489-17-000024 · wf-form4_148676585485774.xml · nonDerivative · entry 1

Owen Randel G · CIK 0001346846 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,067

F1 · shares: Reflects a grant of restricted stock units ("RSUs") that shall vest one year from the date of grant pursuant to the terms of the RSU award agreement or on a pro rata portion upon the termination of service other than for cause, with such pro rata portion determined based on the number of whole months that elapsed from the Grant Date to the termination of service; the vesting and payment of these RSUs will be accelerated if there is a change-in-control of the Company and the Units are not assumed by the surviving entity or otherwise equitably converted or substituted in connection with the Change in Control. The number of RSUs was determined by dividing $90,000 by $43.55, the average of the high and low price of the Company's common stock on the New York Stock Exchange on the day before the grant.

SEC source: 0001209191-16-152782 · doc4.xml · derivative · entry 3

Owen Randel G · CIK 0001346846 · EVP, COO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,203,352 shares

Expires 2021-05-22

F1 · kind: Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3.

F3 · price: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each stock option held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst stock option having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement).

F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each stock option held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst stock option having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement).

SEC source: 0001209191-16-152782 · doc4.xml · derivative · entry 2

Owen Randel G · CIK 0001346846 · EVP, COO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 100,238 shares

Expires 2026-02-24

F1 · kind: Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3.

F3 · price: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each stock option held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst stock option having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement).

F3 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each stock option held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst stock option having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement).

F4 · derivative.exercise_date: These stock options are scheduled to vest in three installments on each of the first three anniversaries of February 24, 2016, subject to the Reporting Person's continued employment

SEC source: 0001209191-16-152782 · doc4.xml · nonDerivative · entry 1

Owen Randel G · CIK 0001346846 · EVP, COO and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., New Amethyst Corp. and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3.

F2 · shares: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each share of common stock held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement).

F2 · price: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each share of common stock held by the reporting person immediately prior to the Merger 2 Effective Time (as defined in the Merger Agreement) was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement).

SEC source: 0001678531-16-000085 · wf-form4_148071623929686.xml · derivative · entry 3

Owen Randel G · CIK 0001346846 · President Ambulatory Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,480

Underlying: Common Stock · 33,480 shares

Expires 2026-02-24

F1 · kind: Acquisition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., Envision Healthcare Corporation (formerly known as New Amethyst Corp.) (the "Company") and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3.

F4 · price: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each stock option held by the reporting person immediately prior to the Merger 2 Effective Time was assumed by the Company and converted into a stock option of the Company having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement).

F4 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each stock option held by the reporting person immediately prior to the Merger 2 Effective Time was assumed by the Company and converted into a stock option of the Company having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement).

F5 · derivative.exercise_date: These stock options are scheduled to vest in three installments on each of the first three anniversaries of February 24, 2016, subject to the Reporting Person's continued employment.

SEC source: 0001678531-16-000085 · wf-form4_148071623929686.xml · derivative · entry 2

Owen Randel G · CIK 0001346846 · President Ambulatory Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 401,920

Underlying: Common Stock · 401,920 shares

Expires 2021-05-22

F1 · kind: Acquisition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., Envision Healthcare Corporation (formerly known as New Amethyst Corp.) (the "Company") and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3.

F4 · price: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each stock option held by the reporting person immediately prior to the Merger 2 Effective Time was assumed by the Company and converted into a stock option of the Company having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement).

F4 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time, each stock option held by the reporting person immediately prior to the Merger 2 Effective Time was assumed by the Company and converted into a stock option of the Company having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement).

SEC source: 0001678531-16-000085 · wf-form4_148071623929686.xml · nonDerivative · entry 1

Owen Randel G · CIK 0001346846 · President Ambulatory Services

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,807

F1 · price: Acquisition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., Envision Healthcare Corporation (formerly known as New Amethyst Corp.) (the "Company") and AmSurg Corp. (the "Merger Agreement"), exempt under Rule 16b-3.

F2 · price: Pursuant to the terms of the Merger Agreement, at the Merger 2 Effective Time (as defined in the Merger Agreement), each share of Envision Healthcare Holdings, Inc. common stock held by the reporting person immediately prior to the Merger 2 Effective Time was assumed by the Company and converted into 0.334 shares of the Company's common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement).

F3 · price: Pursuant to the Merger Agreement, equity-based awards granted pursuant to Envision Healthcare Holdings plans that were outstanding immediately prior to the effective time of the Mergers were converted into corresponding awards in respect of the Company's common stock at the effective time of the Mergers, subject to the same terms and conditions (including applicable vesting requirements) as were applicable to such awards prior to the consummation of the Mergers; provided, that equity-based awards granted pursuant to Envision Healthcare Holdings plans were adjusted to reflect the Exchange Ratio (as defined in the Merger Agreement).